SimpleFX Blog
    Facebook Twitter Instagram
    Thursday, February 2
    Facebook Twitter LinkedIn Telegram YouTube
    SimpleFX BlogSimpleFX Blog
    Banner
    • Home
    • News
    • Tutorials
    • Updates
    • Opinion
    • Trading Academy
    • Trading Schedule
    SimpleFX Blog
    Home»News»U.S. Stocks Rise as Investors Start to Look Beyond the Pandemic
    News

    U.S. Stocks Rise as Investors Start to Look Beyond the Pandemic

    Natalia AlvarezBy Natalia AlvarezApril 17, 2020No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email

    The major U.S. stock markets ended the trading day on Thursday, all in the green. This is even though the rest of the country is still on the verge of economic collapse, with millions registering for unemployment benefits. 

    Twenty-two million Americans have filed for unemployment benefits since March 21 in the wake of the COVID-19 lockdowns. This number represents approximately 13.5% of the total working population, and this number is believed to continue to increase as companies and stores remain shut.

    Last week 5.2 million individuals filed for unemployment, although this is a decrease from the week before, which saw over 6 million people register for the benefits. Although the government has been rolling out stimulus checks and bailout plans for businesses, many experts believe that this is not enough for the economy to bounce back quickly.

    Conversely, although the economy may appear dire, the stock markets seem to have already begun their recovery. The Dow Jones gained 0.14% to end the day at 23,537.68 points. S&P 500 gained 0.58% to finish at 2,799.55, and Nasdaq was the biggest winner, gaining 1.66% to reach 8,532.36 points. The stock markets rallied after President Trump reported that research indicates that America has “passed the peak on new cases.” With the risk of the novel coronavirus decreasing, parts of the country may be able to reopen sooner than initially planned. 

    Gains were also seen in specific companies on Thursday. Shares in Gilead rose by 14% on Thursday as news emerged, stating that drug trials for Remdesivir, a potential treatment option for the coronavirus, is going well. Finding a cure for the virus may mean that America can speed up treatment for patients, and begin to reopen parts of the country that are currently in lockdown, hoping to jumpstart the currently-struggling economy.

    Although gold remains a stable investment, prices fell after the announcement that America may be able to reopen its economy earlier than expected. Spot gold fell in value by 0.2% down to $1,691.93 per ounce. At one point during the day, it was up by 1.3%, but these gains were soon lost after positive economic reports.

    Experts suggest that the news of reopening has seen investors return to other options such as stocks, resulting in a slight dip for gold. Despite this, it is unlikely that the gold value will fall too far, as it appears that the market will continue to be supported post-pandemic.

    Oil prices remain low amid the decreased demand for supply. West Texas Intermediate crude oil prices remained static at $20.26 per barrel, marking its lowest trading value since 2002. Brent crude oil rose by 0.47% to $27.82 per barrel. The Organization of the Petroleum Exporting Countries (OPEC) expects oil demand to decrease 6.9% globally in 2020, although this could continue to drop throughout the year.

    featured
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleGold Hits Record High – Use the Run to Get Additional Profit
    Next Article Unprecedented Oil Collapse Led to U.S. Stocks Sell-out
    Natalia Alvarez

    Related Posts

    Introducing SimpleFX Automatic Affiliate Transfers

    January 31, 2023

    Investors’ Guide to the DAX 40 Index

    January 28, 2023

    Don’t Miss Out On TRON and BNB Staking On SimpleFX

    January 27, 2023

    Leave A Reply Cancel Reply

    Copyright © 2022. SimpleFX
    • SimpleFX WebTrader
    • Unilink Affiliate Tracker

    Type above and press Enter to search. Press Esc to cancel.

    We and our partners use cookies for analytics purposes and to serve personalized ads. You can view our privacy policy here and our cookies policy here
    Accept.
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT